Description
Accession
Q9NQ25
Source
DNA sequence encoding Human SLAMF7/CRACC/CD319 including a C-mFc tag was expressed in HEK293 Cells.
Molecular weight
Recombinant Human SLAMF7/CRACC/CD319 is a protein consisting of amino acid residues [Ser23-Met226] ,The protein has a predicted MW of 48.8 kDa. Due to glycosylation, the protein migrates to 68-72 kDa based on Tris-Bis PAGE result..
Purity
>95%, as determined by SDS-PAGE and HPLC
Biological Activity
see methods section
Endotoxin
Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than 0.1 ng/µg(1EU/µg).
Presentation
Recombinant Human SLAMF7/CRACC/CD319 was lyophilized from 0.2 µm filtered PBS solution pH7.4
Reconstitution
Centrifuge vial to ensure maximal product extraction, recommended:20sec, 5K RPM
Storage
The lyophilized protein is stable for at least 2 years from date of receipt at -20° C.
Usage
This product is for research purposes only.It may not be used for therapeutics or diagnostic purposes.
Biological Process
Molecular function
Methods
Human SLAMF7/CRACC/CD319 Protein Tris-Bis PAGE
- Human SLAMF7 on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Human SLAMF7/CRACC/CD319 Protein SEC-HPLC
- The purity of Human SLAMF7 is greater than 95% as determined by SEC-HPLC.
Human SLAMF7/CRACC/CD319 Protein ELISA Data
- Immobilized Human SLAMF7, mFc Tag at 0.2μg/ml (100μl/Well). Dose response curve for Anti-SLAMF7 Ab., hFc Tag with the EC50 of 13.52ng/ml determined by ELISA.
